Biologic agents in rheumatology: Safety considerations

被引：5
|
作者：
Lee, Susan J. [1 ]
Kavanaugh, Arthur [1 ]
机构：
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Ctr Innovat Therapy, San Diego, CA 92103 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2006年 / 32卷
关键词：
D O I：
10.1016/S0889-857X(07)70003-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 10
页数：8
相关论文
共 50 条
  • [21] Assessing the safety of biologic agents in patients with rheumatoid arthritis
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2012, 51 : V38 - V47
  • [22] The safety and efficacy, and recommendations for the use of biologic drugs in the UK military rheumatology population
    Bennett, Alexander N.
    Green, A. D.
    Rees, J.
    Jones, T.
    Harris, D.
    Etherington, J.
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2013, 159 (01) : 8 - 14
  • [23] Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales
    Ioannidis, John P. A.
    Karassa, Fotini B.
    Druyts, Eric
    Thorlund, Kristian
    Mills, Edward J.
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (11) : 665 - 673
  • [24] Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales
    John P. A. Ioannidis
    Fotini B. Karassa
    Eric Druyts
    Kristian Thorlund
    Edward J. Mills
    Nature Reviews Rheumatology, 2013, 9 : 665 - 673
  • [25] Biologic drugs in pediatric rheumatology
    Sen, Ethan S.
    Ramanan, Athimalaipet V.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (06) : 533 - 535
  • [26] Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis
    Kim, Do Hyun
    Kim, Sung Won
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2021, 14 (03) : 245 - 246
  • [27] Ultrasonic contrast agents: safety considerations reviewed
    ter Haar, GR
    EUROPEAN JOURNAL OF RADIOLOGY, 2002, 41 (03) : 217 - 221
  • [28] Safety of biologic agents for the management of rheumatic diseases during pregnancy
    D'Gama, Jonathan D.
    Bermas, Bonnie L.
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (03) : 184 - 190
  • [29] Response to: The safety and efficacy, and recommendations for the use of biologic drugs in the UK military rheumatology population
    Jackson, Sarah
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2013, 159 (04) : 315 - U82
  • [30] Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology
    Barth, Kaia
    Gill, Harsimrat
    Singh, Namrata
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (02) : 113 - 119
12345